These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1420016)

  • 1. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens.
    Savvas M; Studd JW; Norman S; Leather AT; Garnett TJ; Fogelman I
    Br J Obstet Gynaecol; 1992 Sep; 99(9):757-60. PubMed ID: 1420016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dose-response of percutaneous oestradiol implants on the skeletons of postmenopausal women.
    Studd JW; Holland EF; Leather AT; Smith RN
    Br J Obstet Gynaecol; 1994 Sep; 101(9):787-91. PubMed ID: 7947528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone implants.
    Garnett T; Studd J; Watson N; Savvas M; Leather A
    Obstet Gynecol; 1992 Jun; 79(6):968-72. PubMed ID: 1579324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oestradiol implants on regional and total bone mass: a three-year longitudinal study.
    Ryde SJ; Bowen-Simpkins K; Bowen-Simpkins P; Evans WD; Morgan WD; Compston JE
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):33-8. PubMed ID: 8306478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants.
    Studd J; Savvas M; Waston N; Garnett T; Fogelman I; Cooper D
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1474-9. PubMed ID: 2240090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
    Holland EF; Leather AT; Studd JW
    Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants.
    Naessén T; Persson I; Thor L; Mallmin H; Ljunghall S; Bergström R
    Br J Obstet Gynaecol; 1993 May; 100(5):454-9. PubMed ID: 8518246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study of the effects of long-term percutaneous hormone replacement therapy on bone density.
    Garnett T; Studd J; Watson N; Savvas M
    Obstet Gynecol; 1991 Dec; 78(6):1002-7. PubMed ID: 1945198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.
    Savvas M; Studd JW; Fogelman I; Dooley M; Montgomery J; Murby B
    BMJ; 1988 Jul; 297(6644):331-3. PubMed ID: 3137998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
    Stevenson JC; Cust MP; Gangar KF; Hillard TC; Lees B; Whitehead MI
    Lancet; 1990 Aug; 336(8710):265-9. PubMed ID: 1973969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined oral oestradiol valerate-norethisterone treatment over three years in postmenopausal women: correlation between oestrogen levels and bone mineral density sites.
    Perry W; Wiseman RA
    BJOG; 2000 Nov; 107(11):1401-6. PubMed ID: 11117769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating dehydroepiandrosterone-sulphate decreases even with a slight change in oestradiol.
    Matsui S; Yasui T; Kasai K; Yoshida K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
    J Obstet Gynaecol; 2018 Feb; 38(2):231-235. PubMed ID: 28903616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
    Owen EJ; Siddle NC; McGarrigle HT; Pugh MA
    Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 25-mg percutaneous estradiol implants on the bone mass of postmenopausal women.
    Holland EF; Leather AT; Studd JW
    Obstet Gynecol; 1994 Jan; 83(1):43-6. PubMed ID: 8272305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of percutaneous oestradiol versus oral oestrogens on bone density.
    Palacios S; Menéndez C; Jurado AR; Vargas JC
    Maturitas; 1994 Dec; 20(2-3):209-13. PubMed ID: 7715474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
    Thom MH; Collins WP; Studd JW
    Br J Obstet Gynaecol; 1981 Apr; 88(4):426-33. PubMed ID: 6784745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal therapy with estradiol and testosterone implants: bone protection?
    Britto R; Araújo L; Barbosa I; Silva L; Rocha S; Valente AP
    Gynecol Endocrinol; 2011 Feb; 27(2):96-100. PubMed ID: 20504104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy.
    Wahab M; Ballard P; Purdie DW; Cooper A; Willson JC
    Br J Obstet Gynaecol; 1997 Jun; 104(6):728-31. PubMed ID: 9197878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy.
    Panay N; Versi E; Savvas M
    BJOG; 2000 Aug; 107(8):1012-6. PubMed ID: 10955434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.